MedPath

Testo-100

Testo-100

Approved
Approval ID

593ebdf5-54c6-7fae-e053-2991aa0a8e4a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 4, 2023

Manufacturers
FDA

Advanced Pharmaceutical Technology, Inc.

DUNS: 023237884

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Testosterone,USP

PRODUCT DETAILS

NDC Product Code57377-100
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationSUBCUTANEOUS
Effective DateNovember 4, 2023
Generic NameTestosterone,USP

INGREDIENTS (3)

POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TESTOSTERONEActive
Quantity: 100 mg in 1 1
Code: 3XMK78S47O
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Testo-100 - FDA Drug Approval Details